High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.
about
Circulating MicroRNAs as Biomarkers in Biliary Tract CancersMicroRNA aberrations: An emerging field for gallbladder cancer managementMicroRNA expression and its implications for diagnosis and therapy of gallbladder cancerDeregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential BiomarkersMicroRNA-155 expression is independently predictive of outcome in chordoma.Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinomamiR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.MiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro.Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancerMicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5pMicroRNA-155 expression as a prognostic factor in patients with gallbladder carcinoma after surgical resectionIncreased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinomamiR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancerMicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.The role of microRNAs in gallbladder cancer.The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder.MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ.
P2860
Q26746000-ABA373D9-1330-4CC2-A41B-268D90DCA8E5Q26768416-4C68A9A0-3519-4ECA-89DF-2491C4ADA3C6Q26865667-60FC8CD4-00DE-4909-990F-2F835BF0E9F2Q28073195-67B1231C-AEA8-41DB-8C9E-B8E5F3D52DA9Q33275600-3DB4892C-8CE2-4A22-967D-E3F73C7BC7ECQ33779390-7A306E78-241D-4D7E-86C9-EF207AC7935AQ33802900-F1B6CD5B-9A27-4F3D-BD79-F077615A7DD3Q33805874-125113C6-90C7-4326-A82C-2A9D7E736484Q33850292-FF8D9FF0-DF99-4574-AE14-0BBF81D33DF8Q33858811-0C222945-DEF6-4D97-96A9-49A0B2D55B6CQ33962495-F7233E49-FD06-4896-B4F3-677FD6B3BFA7Q34457236-C4244768-304A-4F5F-8994-191EC9B64B39Q36493057-31A18509-6533-4103-98A2-8DF8EA85974CQ37313015-8282C1EA-49F6-4183-B5F9-2CE00C47E8A2Q37678946-0D3E201E-7CA2-44C5-A8C0-D88512DE8389Q38710244-F3B321AB-6B2D-4B14-94B4-583D1ACCE41DQ38872859-91B59BC7-6DF2-49F4-AF51-C1217D67E5D0Q39099794-02DE3112-7A4F-4136-ABFF-C4833F595D38Q42068869-09B18A0F-DC40-4979-81BF-29353042FA4CQ42362493-82FAAA01-501E-4CEE-A06C-A4BC8D642760
P2860
High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High expression of microRNA-15 ...... vior of gallbladder carcinoma.
@en
High expression of microRNA-15 ...... vior of gallbladder carcinoma.
@nl
type
label
High expression of microRNA-15 ...... vior of gallbladder carcinoma.
@en
High expression of microRNA-15 ...... vior of gallbladder carcinoma.
@nl
prefLabel
High expression of microRNA-15 ...... vior of gallbladder carcinoma.
@en
High expression of microRNA-15 ...... vior of gallbladder carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
High expression of microRNA-15 ...... vior of gallbladder carcinoma.
@en
P2093
Hiroshi Kono
Masafumi Nakamura
Masao Tanaka
Shinichi Aishima
Shunichi Takahata
Takao Ohtsuka
Yasuhisa Mori
Yosuke Nagayoshi
P2860
P356
10.3892/OR.2013.2443
P577
2013-05-09T00:00:00Z